Literature DB >> 10688036

Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells.

G Davies1, W G Jiang, M D Mason.   

Abstract

PURPOSE: The highly variable natural history of prostate carcinoma may be reflected in heterogeneity of invasive potential between tumors.
MATERIALS AND METHODS: We have examined two prostate cancer cell lines of low invasive potential (CAHPV10 and PZHPV7) and three cell lines of high invasive potential (DU-145, PC-3, LNCapFGC), to determine whether specific adhesion molecule profiles correlated with their invasive behavior.
RESULTS: Using an in vitro invasion assay, we demonstrated that DU-145, LNCapFGC and PC-3 cells were highly invasive compared with CA-HPV-10 and PZ-HPV-7 cells. LNCapFGC cells expressed high levels of E-cadherin, alpha-, beta- and gamma-catenin, desmoglein, desmoplakin and GSK3beta using immunoblotting. This was, in general, comparable to immunohistochemical staining. PC-3 cells had no E-cadherin or alpha-catenin, but expressed a high level of the HGF/SF receptor c-Met. In contrast, DU-145 cells were found to express E-cadherin and low levels for all other protein molecules, except c-Met. The DU-145 cell line also lacked alpha-catenin expression. In CA-HPV-10 and PZ-HPV-7 cells, there was no detection of APC, PECAM-1, P-cadherin or Wnt-1. DU-145, LNCapFGC and PC-3 cells formed cell-cell aggregates, which were reduced by inclusion of anti-E-cadherin antibody and the motogen HGF/SF.
CONCLUSION: These results show that prostate cancer cells exhibit a diverse expression of cell-cell adhesion molecules and their signaling intermediates. The expression of these adhesion molecules bears an important relationship with the invasive phenotype of these cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688036

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  KiSS-1 expression in human breast cancer.

Authors:  Tracey A Martin; Gareth Watkins; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Screening biomarkers of prostate cancer by integrating microRNA and mRNA microarrays.

Authors:  Jiayu Feng; Chibing Huang; Xinwei Diao; Minqi Fan; Pingxian Wang; Ya Xiao; Xiao Zhong; Ronghua Wu
Journal:  Genet Test Mol Biomarkers       Date:  2013-08-28

3.  Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.

Authors:  Tumay Ipekci; Ferhat Ozden; Betul Unal; Caner Saygin; Didem Uzunaslan; Erhan Ates
Journal:  Pathol Oncol Res       Date:  2015-06-04       Impact factor: 3.201

4.  Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases.

Authors:  Nanda K Thudi; Chelsea K Martin; Sridhar Murahari; Sherry T Shu; Lisa G Lanigan; Jillian L Werbeck; Evan T Keller; Laurie K McCauley; Joseph J Pinzone; Thomas J Rosol
Journal:  Prostate       Date:  2010-10-18       Impact factor: 4.104

5.  Paracrine communication between malignant and non-malignant prostate epithelial cells in culture alters growth rate, matrix protease secretion and in vitro invasion.

Authors:  Andrea H Greiff; William M Fischer; Inder Sehgal
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

6.  Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3.

Authors:  Mengqian Chen; Ya-Yuan Fu; Chen-Yong Lin; Li-Mei Chen; Karl X Chai
Journal:  Biochim Biophys Acta       Date:  2007-05-01

7.  Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.

Authors:  John C Cheville; R Jeffrey Karnes; Terry M Therneau; Farhad Kosari; Jan-Marie Munz; Lori Tillmans; Eati Basal; Laureano J Rangel; Eric Bergstralh; Irina V Kovtun; C D Savci-Heijink; Eric W Klee; George Vasmatzis
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

8.  The role of vascular endothelial growth inhibitor in wound healing.

Authors:  Kevin P Conway; Patricia Price; Keith G Harding; Wen G Jiang
Journal:  Int Wound J       Date:  2007-03       Impact factor: 3.315

9.  Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer.

Authors:  Herman Fernando; Tracey A Martin; Anthony Douglas-Jones; Howard G Kynaston; Robert E Mansel; Wen G Jiang
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

10.  Integrin involvement in freeze resistance of androgen-insensitive prostate cancer.

Authors:  J G Baust; D P Klossner; R G Vanbuskirk; A A Gage; V Mouraviev; T J Polascik; J M Baust
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-01-12       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.